|
1
|
Jemal A, Bray F, Center MM, Ferlay J, Ward
E and Forman D: 2011 Global cancer statistics. CA Cancer J Clin.
61:69–90. 2011. View Article : Google Scholar
|
|
2
|
Ramalingam S and Belani C: Systemic
chemotherapy for advanced non-small cell lung cancer: recent
advances and future directions. Oncologist. 13:5–13. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Sharma SV, Bell DW, Settleman J and Haber
DA: Epidermal growth factor receptor mutations in lung cancer. Nat
Rev Cancer. 7:169–181. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
4
|
Mendelsohn J: Blockade of receptors for
growth factors: an anticancer therapy - the fourth annual Joseph H.
Burchenal American Association of Cancer Research Clinical Research
Award Lecture. Clin Cancer Res. 6:747–753. 2000.
|
|
5
|
Cohen MH, Williams GA, Sridhara R, Chen G,
McGuinn WD Jr, Morse D, Abraham S, Rahman A, Liang C, Lostritto R,
Baird A and Pazdur R: United States Food and Drug Administration
Drug Approval summary: Gefitinib (ZD1839; Iressa) tablets. Clin
Cancer Res. 10:1212–1218. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Wu JY, Shih JY, Chen KY, Yang CH, Yu CJ
and Yang PC: Gefitinib therapy in patients with advanced non-small
cell lung cancer with or without testing for epidermal growth
factor receptor (EGFR) mutations. Medicine. 90:159–167. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lacouture ME: Mechanisms of cutaneous
toxicities to EGFR inhibitors. Nat Rev Cancer. 6:803–812. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Jiang H: Overview of gefitinib in
non-small cell lung cancer: an Asian perspective. Jpn J Clin Oncol.
39:137–150. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Wang GS: Medical uses of mylabris in
ancient China and recent studies. J Ethnopharmacol. 26:147–162.
1989. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chen YN, Chen JC, Yin SC, Wang GS, Tsauer
W, Hsu SF and Hsu SL: Effector mechanisms of norcantharidin-induced
mitotic arrest and apoptosis in human hepatoma cells. Int J Cancer.
100:158–165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Hill TA, Stewart SG, Ackland SP, Gilbert
J, Sauer B, Sakoff JA and McCluskey A: Norcantharimides, synthesis
and anticancer activity: Synthesis of new norcantharidin analogues
and their anticancer evaluation. Bioorg Med Chem. 15:6126–6134.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Fan YZ, Fu JY, Zhao ZM and Chen CQ:
Inhibitory effect of norcantharidin on the growth of human
gallbladder carcinoma GBC-SD cells in vitro. Hepatobiliary Pancreat
Dis Int. 6:72–80. 2007.PubMed/NCBI
|
|
13
|
Peng F, Wei YQ, Tian L, Yang L, Zhao X, Lu
Y, Mao YQ, Kan B, Lei S, Wang GS, Jiang Y, Wang QR, Luo F, Zou LQ
and Liu JY: Induction of apoptosis by norcantharidin in human
colorectal carcinoma cell lines: involvement of the CD95
receptor/ligand. J Cancer Res Clin Oncol. 128:223–230. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Liao HF, Su SL, Chen YJ, Chou CH and Kuo
CD: Norcantharidin preferentially induces apoptosis in human
leukemic Jurkat cells without affecting viability of normal blood
mononuclear cells. Food Chem Toxicol. 45:1678–1687. 2007.
View Article : Google Scholar
|
|
15
|
Chen YJ, Shieh CJ, Tsai TH, Kuo CD, Ho LT,
Liu TY and Liao HF: Inhibitory effect of norcantharidin, a
derivative compound from blister beetles, on tumor invasion and
metastasis in CT26 colorectal adenocarcinoma cells. Anticancer
Drugs. 16:293–299. 2005. View Article : Google Scholar
|
|
16
|
Chen YJ, Tsai YM, Kuo CD, Ku KL, Shie HS
and Liao HF: Norcantharidin is a small-molecule synthetic compound
with anti-angiogenesis effect. Life Sci. 85:642–651. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Yang EB, Tang WY, Zhang K, Cheng LY and
Mack PO: Norcantharidin inhibits growth of human HepG2
cell-transplanted tumor in nude mice and prolongs host survival.
Cancer Lett. 117:93–98. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Fan YZ, Zhao ZM, Fu JY, Chen CQ and Sun W:
Norcantharidin inhibits growth of human gallbladder carcinoma
xenografted tumors in nude mice by inducing apoptosis and blocking
the cell cycle in vivo. Hepatobiliary Pancreat Dis Int. 9:414–422.
2010.PubMed/NCBI
|
|
19
|
Liu XH, Blazsek I, Comisso M, Legras S,
Marion S, Quittet P, Anjo A, Wang GS and Misset JL: Effects of
norcantharidin, a protein phosphatase type-2A inhibitor, on the
growth of normal and malignant haemopoietic cells. Eur J Cancer.
31A:953–963. 1995.PubMed/NCBI
|
|
20
|
McCluskey A, Ackland SP, Gardiner E,
Walkom CC and Sakoff JA: The inhibition of protein phosphatases 1
and 2A: a new target for rational anti-cancer drug design?
Anticancer Drug Des. 16:291–303. 2001.PubMed/NCBI
|
|
21
|
Hill TA, Stewart SG, Sauer B, Gilbert J,
Ackland SP, Sakoff JA and McCluskey A: Heterocyclic substituted
cantharidin and norcantharidin analogues-synthesis, protein
phosphatase (1 and 2A) inhibition, and anti-cancer activity. Bioorg
Med Chem Lett. 17:3392–3397. 2007. View Article : Google Scholar
|
|
22
|
Wu CW, Ping YH, Yen JC, Chang CY, Wang SF,
Yeh CL, Chi CW and Lee HC: Enhanced oxidative stress and aberrant
mitochondrial biogenesis in human neuroblastoma SH-SY5Y cells
during methamphetamine induced apoptosis. Toxicol Applied
Pharmacol. 220:243–251. 2007. View Article : Google Scholar
|
|
23
|
Luan J, Duan H, Liu Q, Yagasaki K and
Zhang G: Inhibitory effects of norcantharidin against human lung
cancer cell growth and migration. Cytotechnology. 62:349–355. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hong CY, Huang SC, Lin SK, Lee JJ, Chueh
LL, Lee CH, Lin JH and Hsiao M: Norcantharidin-induced post-G(2)/M
apoptosis is dependent on wild-type p53 gene. Biochem Biophys Res
Commun. 276:278–285. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Liao HF, Chen YJ, Chou CH, Wang FW and Kuo
CD: Norcantharidin induces cell cycle arrest and inhibits
progression of human leukemic Jurkat T cells through
mitogen-activated protein kinase-mediated regulation of
interleukin-2 production. Toxicol In Vitro. 25:206–212. 2011.
View Article : Google Scholar
|
|
26
|
Yang PY, Chen MF, Kao YH, Hu DN, Chang FR
and Wu YC: Norcantharidin induces apoptosis of breast cancer cells:
involvement of activities of mitogen activated protein kinases and
signal transducers and activators of transcription. Toxicol In
Vitro. 25:699–707. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Millward TA, Zolnierowicz S and Hemmings
BA: Regulation of protein kinase cascades by protein phosphatase
2A. Trends Biochem Sci. 24:186–191. 1999. View Article : Google Scholar : PubMed/NCBI
|
